2026-09-30 · contested story
Will Trump administration weaken protections for human research subjects?
The stated research topic — whether the Trump administration will weaken protections for human research subjects by streamlining the Common Rule — is essentially absent from the scraped source set. Of 22 articles supplied, only one (National Review, Source 2) substantively addresses human-subject research protections, and it is a 2012 Wesley J. Smith column about a Texas Medical Board stem-cell policy, predating the current administration entirely. That piece warns against 'circumventing the Common Rule for human subject studies' and charging patients for unproven therapies, calling that road one that 'leads to biotech anarchy.' No article in the set describes any Trump administration action on the Common Rule, informed consent, or IRB oversight.
How each side frames it
What each side left out
22 sources analyzed
Politico National Review Just Security New York Post The Federalist National Review Richmond Times-Dispatch Boston Herald The Federalist Investor's Business Daily Boston Herald The Federalist New York Post Newsmax National Review Richmond Times-Dispatch The Daily Signal The Daily Signal New York Post Richmond Times-Dispatch Richmond Times-Dispatch Newsmax